1,2-diarylimidazoles for use as CBI modulators

Details for Australian Patent Application No. 2006290553 (hide)

Owner AstraZeneca AB

Inventors Sorensen, Henrik; Ahlqvist, Matti; Lundqvist, Robert; Cheng, Leifeng

Agent Davies Collison Cave

Pub. Number AU-A-2006290553

PCT Pub. Number WO2007/031720

Priority 0518817.2 15.09.05 GB

Filing date 12 September 2006

Wipo publication date 22 March 2007

International Classifications

C07D 233/90 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/4178 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

3 April 2008 PCT application entered the National Phase

  PCT publication WO2007/031720 Priority application(s): WO2007/031720

7 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006290555-Polymer mixtures for crosslinked fluids

2006290550-Mass labels